Nalaganje...
The Protein Kinase 2 Inhibitor CX-4945 Regulates Osteoclast and Osteoblast Differentiation In Vitro
Drug repositioning can identify new therapeutic applications for existing drugs, thus mitigating high R&D costs. The Protein kinase 2 (CK2) inhibitor CX-4945 regulates human cancer cell survival and angiogenesis. Here we found that CX-4945 significantly inhibited the RANKL-induced osteoclast dif...
Shranjeno v:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Korea Society for Molecular and Cellular Biology
2013
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3887940/ https://ncbi.nlm.nih.gov/pubmed/24293011 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10059-013-0184-9 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|